Context For women, impact of cardiovascular risk factors measured in young adulthood, particularly favorable (low-risk) profile, on mortality has been difficult to assess due to low short-term death rates.
Y OUNG ADULT MEN AND MIDDLEaged men and women with favorable levels of all major cardiovascular risk factors, ie, low-risk status, have much lower agespecific risks for cardiovascular disease (CVD) and all-cause mortality than those with adverse levels of 1 or more risk factors. 1 However, the impact of a favorable cardiovascular risk profile in young women on subsequent mortality has only been estimated statistically using coronary heart disease (CHD) risk prediction models. 2 In this study, we examined the relationship of low CHD/CVD risk and individual risk factors in young women to long-term CHD, CVD, and all-cause mortality.
METHODS
From 1967 to 1973, the Chicago Heart Association (CHA) Detection Project in Industry Study screened 39 522 employed Chicago-area men and women aged 18 years and older. Standardized examination methods, follow-up pro-cedures, and death certificate coding were used. [3] [4] [5] [6] [7] Vital status was ascertained through 2001, with an average (SD) follow-up of 31 (1.3) years. Informed consent was obtained from each study participant. The study has been periodically approved by the Northwestern University Institutional Review Board.
Of 7748 women (baseline ages 18-39 years), 446 were excluded for the following reasons: baseline CHD (n = 7); major electrocardiographic (ECG) abnormality (n=403); missing data on smoking, blood pressure (BP), serum cholesterol level, body mass index (BMI), diabetes, or education (n=36).
Eligible women (n=7302) were classified into 4 risk groups according to baseline CVD risk status. Low-risk status was defined as favorable levels of all the following: systolic BP (SBP) 120 mm Hg or less and diastolic BP (DBP) 80 mm Hg or less and not taking antihypertensive medication, serum cholesterol level less than 200 mg/dL (Ͻ5.17 mmol/L) and not taking cholesterol-lowering medication, BMI less than 25.0, no diabetes, and not smoking. Participants not at low risk were classified as having 0 risk factors high but 1 or more unfavorable, any 1 only, or 2 or more of the following: SBP 140 mm Hg or higher or DBP 90 mm Hg or higher or taking antihypertensive medication, serum cholesterol level 240 mg/dL or higher (Ն6.21 mmol/L) or taking cholesterol-lowering medication, BMI 30.0 or higher, diabetes, and cigarette smoking. Unfavorable levels are defined as SBP 121 to 139 mm Hg and DBP 81 to 89 mm Hg and not taking antihypertensive medication, serum cholesterol level 200 to 239 mg/dL (5.17-6.18 mmol/L) and not taking cholesterol-lowering medication, and BMI 25.0 to 29.9. Race/ethnicity was assessed by interviewers to clarify reasons for the higher CVD rates in blacks than whites, a major US problem requiring additional research then and now.
Age-adjusted CHD, CVD, and allcause mortality rates per 10000 person-years of follow-up were computed by risk category. Cox proportional hazards regression was used to calculate mortality hazard ratios (HRs) and 95% confidence intervals (CIs) by baseline risk category, adjusted for baseline age only and for other risk factors. Tests of the proportional hazards assumption showed no violation. Models were computed to estimate the HR and 95% CI (PϽ.05) for individual risk factors and for the low-risk group compared with other strata. Kaplan-Meier cumulative mortality curves were also plotted for the 4 risk categories. All analyses were conducted with SAS statistical software version 8.02 (SAS Institute Inc, Cary, NC).
RESULTS
Of the 7302 young women, 1469 (20.1%) were classified as low risk; a majority (58.5%) of the cohort had 1 Abbreviations: BMI, body mass index, calculated as weight in kilograms divided by the square of height in meters; CHD, coronary heart disease; CVD, cardiovascular disease; ECG, electrocardiogram. SI conversion factor: to convert cholesterol levels from mg/dL to mmol/L, multiply by 0.0259. *Data are expressed as mean (SD) unless otherwise noted.
†With exclusion of persons with history or ECG evidence of CHD and major electrocardiographic abnormalities, low risk is defined as all of the following: baseline serum cholesterol level less than 200 mg/dL (Ͻ5.17 mmol/L) and not currently taking cholesterol-lowering medication; systolic blood pressure 120 mm Hg or less, diastolic blood pressure 80 mm Hg or less, not currently taking antihypertensive medication; not currently smoking; no diabetes; and BMI less than 25.0. Persons who were not low risk were further classified into 3 groups as having 0 but 1 or more unfavorable, any 1 only, or 2 or more of the following 5 risk factors: cholesterol 240 mg/dL or higher (Ն6.21 mmol/L) or taking cholesterol-lowering medication, systolic blood pressure 140 mm Hg or higher or diastolic blood pressure 90 mm Hg or higher or currently taking antihypertensive medication, current smoking, diabetes, and BMI greater than 30.0. or more high-risk factors (TABLE 1) . Low-risk women tended to be younger, white, and better educated. During 31 years of follow-up, there were 47 CHD deaths, 94 CVD deaths, and 469 deaths from all causes ( Table 1) .
All risk factors considered individually were related to CHD and CVD death with cigarette smoking and BMI, significantly so in multivariate analyses (TABLE 2) .
Age-adjusted CHD mortality rates were similar for low-risk women and those with 0 risk factors high but 1 or more unfavorable and were much lower than for women with 1 only risk factor or 2 or more risk factors high. Women with 2 or more risk factors high had the highest CHD mortality rates (TABLE 3) . Findings were similar for CVD and allcause mortality, eg, CVD mortality rate per 10000 person-years for women with 2 or more risk factors high was 9.1, about 6 times that of low-risk women (1.5). With adjustment for age, race, and minor ECG abnormalities, HRs for 31-year allcause mortality were lowest for lowrisk women and increased with the number of risk factors. Results stratified by race were similar (data not shown). Kaplan-Meier cumulative mortality curves depict similar results (FIGURE).
COMMENT
Among young women without baseline major ECG abnormalities or prevalent CHD at baseline, 31-year risks of CHD, CVD, and all-cause mortality were markedly lower for those who were low-risk compared with others. The presence of high levels of major risk factors was associated with much higher mortality risk. 
FAVORABLE RISK PROFILE IN YOUNG WOMEN AND LONG-TERM RISK OF MORTALITY
Prospective population-based research involving large cohorts with long-term follow-up into older age has delineated multiple favorable consequences of baseline low-risk status. For the small percentage of young men and middle-aged men and women who were low-risk at baseline compared with all others, CHD/CVD is rare (endemic) not epidemic; CHD, CVD, and all-cause mortality rates are remarkably lower. 1, 8 Persons at low risk earlier in life experience higher quality of life, lower medication use and prevalence of clinical diseases, 9, 10 less subclinical coronary atherosclerosis, 11 and also substantially lower average annual health care costs in older age 12 compared with others.
To our knowledge, the relationship of low-risk status to subsequent mortality has not been previously assessed in young women. The few reports on women have presented estimates from statistical extrapolation, 2 have defined low risk alternatively, 13 or did not include younger women. 1 A report describing CHD risk prediction models derived from Framingham data estimated that 10-year incidence of fatal and nonfatal CHD was 1% or less for women ages 30 to 39 years who were low risk (ie, no diagnosed diabetes, nonsmoker, with optimal BP and cholesterol levels). 2 In the Nurses' Health Study, low-risk status was defined as nonsmoking, moderate/vigorous exercise 30 minutes or more per day, BMI less than 25, moderate alcohol consumption, and a diet score in the top 2 quintiles. Low-risk women (only 3% of 84 129 women, baseline ages 30-55 years) had an 83% lower 14-year risk of fatal and nonfatal coronary events compared with others. 13 In a previous report among middleaged women (baseline ages 40-59 years) from the CHA study, CHD and CVD mortality rates for those at low risk were lower by 79% and 73%, respectively, and all-cause mortality was lower by 40% compared with those with adverse levels of 1 or more risk factors. 1 With over 3 decades of followup, our results now reveal the impor-tance of a low-risk profile in young women. Of note, our study incorporates BMI in the low-risk definition since overweight/obesity is a major independent CVD risk factor that is increasingly prevalent among Americans. [14] [15] [16] Limitations of this study include measurement of risk factors once only at baseline, which would likely lead to underestimation of the impact of risk status, ie, regression dilution bias toward the null. Furthermore, information on dietary habits and physical activity was not collected. Also, the use of death certificates for ascertaining cause of death may result in overestimation of CHD mortality. 17 Nevertheless, it is unlikely that this would differ systematically across risk strata.
Our findings show that for young women, a low cardiovascular risk profile is associated with lower long-term CHD, CVD, and all-cause mortalityresults in concert with previous findings on young men and middle-aged men and women. 1 They demonstrate that among persons at low risk earlier in life, CHD and CVD cease to occur at epidemic rates. These data underscore the importance of a national public policy priority emphasizing preven-tion and control of all major CVD risk factors by lifestyle approaches from conception, weaning, childhood, and youth on to increase proportions of the population at low CVD risk. 
